Tag: biosimilars billing
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Acetaminophen vs NSAIDs in Pregnancy: Trimester Safety Guide
Jun, 15 2026
Dermatomyositis and Polymyositis: Symptoms, Diagnosis, and Modern Treatment Options
Jul, 20 2026
Quality Assurance Units: The Power of Independent Oversight in Production
Apr, 23 2026
Coumadin: How This Classic Blood Thinner Impacts Your Health and Daily Life
May, 23 2025
Alternatives to Sumatriptan: Exploring the Options for Migraine Relief
Mar, 28 2025